课题基金 / 基金详情

基于“脾滋胎气”补脾益气法靶向PD-1/PD-L1通路调节蜕膜巨噬细胞极化干预TAI合并流产机制研究

批准号:
82104755
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
李品
依托单位:
学科分类:
中医内科学
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
李品

项目摘要

结项摘要

相似基金

相关文献

中文摘要
甲状腺自身免疫(TAI)与妊娠不良结局相关性是本领域研究热点,其中单纯甲状腺抗体增高(单纯TAI)可不依赖TSH降低而独立导致流产发生,目前尚无充分证据表明LT4对妊娠维持有效。蜕膜巨噬细胞极化失衡为本病西医病理基础,脾气不足、胎失滋养为中医病机,两者存在一定相关性。故申请人以“脾滋胎气”理论为基础,取“滋化源、举中气、御邪气”之意,采用中医经典方剂“补中益气汤”干预本病,前期研究表明,本方剂在TAI防治中具有良好疗效。为进一步探索疗效机制,申请人提出科研假说:补中益气汤能够通过激活PD-1/PD-L1信号通路,经激活胞内PI3K/Akt/mTOR、MEK/ERK信号通路转导,抑制蜕膜巨噬细胞糖酵解代谢,维持蜕膜巨噬细胞极化平衡,防治TAI合并流产。申请人拟从体内、体外多水平开展实验,重点挖掘TAI合并流产过程中蜕膜巨噬细胞代谢、极化特点及其通路调控机制,从而为中药新药研制奠定基础。
英文摘要
The relationship between thyroid autoimmunity (TAI) and adverse pregnancy outcomes is a research hotspot of the endocinology. The increase of thyroid antibody alone can lead to abortion without the decrease of TSH independently. There is no sufficient evidence to show that LT4 is effective in maintaining pregnancy under this stituation .The imbalance of decidual macrophage polarization is the pathological basis of Western medicine, meanwhile, the deficiency of spleen qi and fetal loss of nourishment are the pathogenesis pattern of the traditional Chinese medicine, and there is definitely a certain correlation between the two theory. Therefore, based on the theory of "spleen nourishing fetal Qi", the applicant adopted the classical TCM prescription "Buzhong Yiqi Decoction" to intervene the disease, taking the method of "nourishing the source, lifting the middle Qi and resisting the evil Qi". The previous research showed that this prescription had good curative effect in the prevention and treatment of TAI. In order to further explore the mechanism of curative effect, the applicant proposed a scientific research hypothesis: "Buzhong Yiqi Decoction" can inhibit glycolysis metabolism of decidual macrophages, maintain polarization balance of decidual macrophages, and prevent abortion of TAI by activating PD-1 / PD-L1 signal pathway and PI3K / Akt / mTOR and MEK / ERK signal pathway. The applicant intends to carry out experiments at multiple levels in vivo and in vitro, focusing on the metabolism, polarization characteristics and pathway regulation mechanism of decidual macrophages in the process of TAI complicated with abortion, so as to lay a foundation for creating the new traditional Chinese medicine.
本项目通过提取小鼠甲状腺球蛋白,二次免疫诱导甲状腺自身免疫且甲状腺功能正常小鼠,并通过合笼后,造TAI合并妊娠小鼠模型。通过观察小鼠早期妊娠胚胎情况,运用补中益气汤可以能够有效的降低小鼠TgAb水平,同时降低TAI妊娠小鼠胚胎吸收率。通过病理分析,补中益气汤能有效改善甲状腺组织病理炎症评分以及增加蜕膜组织中螺旋动脉管腔内径,并对蜕膜组织中胚胎植入水平标志物中IGFBP-7、VEGF、PDGF-AA的表达具有升高作用,证实了补脾益气法对于TAI合并妊娠小鼠有促进胚胎植入,保护胚胎作用。采用Western-blot、PT-PCR、ELisa、流式细胞术和免疫组化对脾脏、蜕膜组织、血清中巨噬细胞M1/M2数量、主要分泌细胞因子的水平、标志物蛋白表达水平以及转录因子水平进行检测,联合检测蜕膜组织中PD-1/PD-L1调控相关指标分析,结果提示:TAI合并妊娠小鼠中存在PD-1/PD-L1的通路抑制,巨噬细胞M1/M2极化失衡,M1极化处于相对优势地位,而应用补中益气汤后能够降低M1标志物iNOS和提高M2标志物Arg-1的蛋白表水平,提高巨噬细胞表面CD163的表达,降低CD86的表达水平,并对IRF4、IRF5同样有转录水平同样有转录调节作用,从而证实补中益气汤能够激活PD-1/PD-L1通路,流式细胞术证明巨噬细胞M2中PD-1的表达水平增高,从而促进巨噬细胞M2极化增多,M1相对降低,从而调节蜕膜组织巨噬细胞M1/M2极化平衡。此外,在提取的体外人蜕膜巨噬细胞实验中,通过不同分组的流式细胞术检测、Elisa、Western-blot、PCR以及seahorse能量分析检测,证实了补中益气汤激活PD-1通路可激活P13K/AKT-mTOR、MEK/ERK,并抑制巨噬细胞糖酵解水平,促进蜕膜组织M1/M2极化平衡。本研究结合体内外实验的共同验证,PD-1/PD-L1抑制,巨噬细胞M1/M2极化失衡是TAI合并流产的重要机制,补中益气汤能够激活PD1/PD-L1通路,激活P13K/AKT-mTOR、MEK/ERK,抑制蜕膜巨噬细胞糖酵解水平,下调巨噬细胞M1极化,使M1/M2极化平衡,从而防治TAI合并流产。该研究为“脾滋胎气”中医病机理论的科学内涵和生物学基础提供依据,为自身免疫甲状腺病合并流产相关临床应用,以及中药新药研制奠定基础。
国内基金
海外基金